Wealthfront Advisers »

Denali Therapeutics shares owned by Wealthfront Advisers

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Wealthfront Advisers from 13F filings

Historical chart of Wealthfront Advisers investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Wealthfront Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Wealthfront Advisers

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.6M 20k 131.29

More positions owned by Wealthfront Advisers

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ishares Core Msci Emkt (IEMG)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Schwab Strategic Tr Us Tips Etf (SCHP)
Ishares Tr Core Div Grwth (DGRO)
Vanguard Index Fds Real Estate Etf (VNQ)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Extend Mkt Etf (VXF)

View all positions for Wealthfront Advisers

Top funds holding Denali Therapeutics

BlackRock
Vanguard Group
Baillie Gifford & Co
FMR
T. Rowe Price Investment Management
Ubs Global Asset Management Americas
State Street Corporation
Temasek Holdings
Capital Research Global Investors
Baker Bros. Advisors
Alliancebernstein
Geode Capital Management
Crestline Management
Holocene Advisors
Point72 Asset Management

View all funds holding Denali Therapeutics